Researchers Angelika Mühlebner

Angelika Mühlebner

Associate Professor - medical

Strategic program(s):

Biography

Medical University Vienna, Vienna, Austria	MD	31-07-2008	medicine
Medical University Vienna, Vienna, Austria		31-08-2009	neuropathology residency
University Hospital Erlangen, Erlangen, Germany	PhD	12-05-2012	epilepsy-associated pathology
Medical University Vienna, Vienna, Austria		31-03-2014	pediatrics residency
Amsterdam Medical Center, AMC, Amsterdam, The Netherlands		31-12-2015	postdoctoral researcher
Amsterdam Medical Center, AMS, Amsterdam, The Netherlands		30-09-2020	pathology residency
University Medical Center Utrecht, Utrecht, The Netherlands	Associate professor	21-12-2021	fellowship neuropathology
University Medical Center Utrecht, Utrecht, The Netherlands		ongoing	neuropathology, head of cytology unit

Strategic program(s):

Contact

amuhleb2@umcutrecht.nl

Pure profile

Research groups

Neuropathology

Research aim

Our aim is to drive and improve state-of-the-art diagnostics, enhance knowlegde and advance targeted interventions for individuals affected by neurological disorders.

Go to group

Recent publications

All publications

Impaired GABAergic regulation and developmental immaturity in interneurons derived from the medial ganglionic eminence in the tuberous sclerosis complex Mirte Scheper, Frederik N F Sørensen, Gabriele Ruffolo, Alessandro Gaeta, Lilian J Lissner, Jasper J Anink, Irina Korshunova, Floor E Jansen, Kate Riney, Wim van Hecke, Angelika Mühlebner, Konstantin Khodosevich, Dirk Schubert, Eleonora Palma, James D Mills, Eleonora Aronica
Acta Neuropathologica, 2024, vol. 147

T2-FLAIR Mismatch: An Imaging Biomarker for Children's MYB/MYBL1-Altered Diffuse Astrocytoma or Angiocentric Glioma. E A van Maren, J W Dankbaar, P Wesseling, S Plasschaert, A Muhlebner, E W Hoving, P A Robe, T J Snijders, R Hoogendijk, M E G Kranendonk, M H Lequin
AJNR. American journal of neuroradiology, 2024, vol. 45, p.747-752

Diffuse, IDH-wildtype gliomas in adults with minimal histological change and isolated TERT promoter mutation L P Priesterbach-Ackley, F Cordier, P de Witt Hamer, T J Snijders, P A Robe, B Küsters, W W J de Leng, W F A den Dunnen, D Brandsma, C Jansen, P Wesseling, A Muhlebner
Acta Neuropathologica, 2024, vol. 148

Clinical characteristics and survival outcomes of patients with primary central nervous system lymphoma treated with high-dose methotrexate-based polychemotherapy and consolidation therapies Fleur A de Groot, Tim J A Dekker, Jeanette K Doorduijn, Stefan Böhringer, Mirian Brink, Ruben A L de Groen, Lorraine M de Haan, F J Sherida H Woei-A-Jin, Troy Noordenbos, Aniko Sijs-Szabo, Mirjam A Oudshoorn, King H Lam, Arjan Diepstra, Liane C J Te Boome, Valeska Terpstra, Lara H Bohmer, Alina Nicolae, Eduardus F M Posthuma, Lianne Koens, Marc F Durian, Jeroen Stavast, Marjolein W M van der Poel, Myrurgia Abdul Hamid, Wendy B C Stevens, Sjo L M van Rooij, Rimke S Oostvogels, Angelika Mühlebner, Karen J Neelis, Michiel van den Brand, Thomas Tousseyn, Daan Dierickx, Okke de Weerdt, Aart Beeker, Patty M Jansen, Marie José Kersten, Josée M Zijlstra, Martine E D Chamuleau, Hendrik Veelken, Jacoline C E Bromberg, Marcel Nijland, Joost S P Vermaat
European Journal of Cancer, 2024, vol. 213

Somatostatin receptor 2A expression in von Hippel-Lindau-related hemangioblastomas Saya Ahmad, Angelika Muhlebner, Tom J Snijders, Wendy W de Leng, Tatjana Seute, Rachel S van Leeuwaarde
Cancer, 2024, vol. 130, p.3473-3479